U.S. Semiconductors Stock News

Earlier in November 2025, Expeditors International of Washington reported quarterly earnings and revenue that exceeded Wall Street expectations despite a weak freight market. The results highlighted growth in airfreight tonnage and strong customs brokerage and fee-based services performance, even as analysts maintained a cautious Hold consensus. Next, we’ll examine how this resilient fee-based performance shapes Expeditors International’s broader investment narrative over the past...

DHT Holdings, Inc. reported fourth-quarter 2025 revenue of US$144.16 million and net income of US$66.07 million, and declared a US$0.41 per-share cash dividend, its 64th consecutive quarterly payout, payable on February 26, 2026, to shareholders of record on February 19. The decision to distribute 100% of ordinary net income as a dividend underlines DHT’s emphasis on returning cash to shareholders while highlighting how its earnings power currently supports this capital allocation...

In February 2026, 10x Genomics reported fourth-quarter 2025 revenue of US$166.03 million with a reduced net loss of US$16.25 million, and filed a US$138.83 million shelf registration for 7,661,479 Class A shares tied to an employee stock plan. Alongside improved full-year 2025 loss metrics and cautious 2026 revenue guidance, 10x Genomics deepened its role in AI-driven cancer research through the PharosAI collaboration using its Xenium spatial platform. Next, we’ll assess how stronger cost...

Coeur Mining (CDE) is back in focus after a wave of bullish analyst updates related to its New Gold acquisition, expectations for strong near term free cash flow, and supportive gold and silver prices. See our latest analysis for Coeur Mining. At a share price of US$22.42, Coeur Mining has seen a 52.52% 90 day share price return and a very large 1 year total shareholder return of 248.68%, with multi year total shareholder returns also very strong. This suggests momentum has been building as...

In recent weeks, CSW Industrials reported a mixed Q3 update with softer results in Contractor Solutions and residential HVAC/R, while Senior Vice President and General Counsel Luke Alverson sold 500 shares for about US$158,010. The combination of weaker segment trends, tariff and acquisition-related margin pressure, and internal share sales has sharpened investor focus on the quality and resilience of CSW Industrials’ growth drivers. We’ll now examine how these softer Q3 trends and the...

Corebridge Financial reported past fourth-quarter 2025 revenue of US$6,767 million, up from US$6,600 million a year earlier, but net income fell to US$814 million from US$2,171 million, with the full year swinging to a US$366 million net loss and a basic loss per share of US$0.68 from prior earnings. Alongside these mixed results, Corebridge continued to return capital through a higher quarterly dividend of US$0.25 per share and completion of roughly US$4.40 billions in buybacks, while also...

Recently, Signet Jewelers was highlighted for strong seasonal momentum as Valentine’s Day spending lifted expectations for higher sales during this key jewelry shopping period. This short-term boost in demand underscores how dependent the retailer’s performance can be on holiday-driven purchasing patterns and consumer sentiment. We’ll now examine how this holiday-driven optimism around Valentine’s Day spending aligns with or challenges the existing investment narrative for Signet. Invest in...

Resideo Technologies stock snapshot after recent price moves Resideo Technologies (REZI) has drawn fresh attention after recent share price swings, with the stock last closing at $35.83. Investors are weighing its recent returns, profitability profile, and value score in relation to its current valuation. See our latest analysis for Resideo Technologies. The recent 0.73% 1 day share price return comes after a softer 30 day share price return of 5.41%. However, the 90 day share price return of...

Gilead Sciences and Kite are highlighting new late stage HIV and CAR T cell therapy data, along with regulatory updates, at upcoming medical meetings in 2026. Gilead Sciences plans to present Phase 3 results for a new single tablet HIV regimen and updates on HIV cure research at CROI 2026. Kite received an FDA label update for Yescarta that removes a key limitation of use in relapsed or refractory primary central nervous system lymphoma, expanding eligible patients for this CAR T cell...

If you are wondering whether ONEOK’s current share price fairly reflects its underlying value, you are not alone. This article is built to help you connect the recent price action with the fundamentals. ONEOK closed at US$86.11, with returns of 3.2% over the past week, 15.7% over the last 30 days, 15.8% year to date and a 7.8% decline over the past year, alongside longer term returns of 52.4% over 3 years and 150.4% over 5 years. Recent news coverage around ONEOK has focused on its role as a...

Advance Auto Parts recently reported fourth-quarter 2025 results showing US$1,973 million in sales and a return to profitability with US$6 million in net income, alongside improved margins and positive comparable sales growth. The company paired this earnings recovery with 2026 guidance for US$8,485 million to US$8,575 million in net sales and affirmed a regular US$0.25 per-share dividend, underscoring its ongoing turnaround and capital-return plans. We’ll now examine how this earnings...

Modine Manufacturing (NYSE:MOD) is shifting toward a higher margin, pure play climate solutions business following the spin off of its Performance Technologies segment. The company is seeing growing traction in cooling solutions for AI data centers and is pursuing potential long term agreements with major hyperscale customers. These changes represent a material reset of Modine's business mix and risk profile that goes beyond routine earnings updates. For you as an investor, the key point is...

If you are wondering whether SoFi Technologies at around US$19.61 is a bargain or already pricing in a lot of optimism, you are not alone. The stock has had a mixed run, with a 7.4% decline over the past week, a 25.0% decline over the past month, and a 28.6% decline year to date, while still showing a 16.5% return over the past year and a very large 3 year gain alongside a 2.5% decline over 5 years. These swings have kept SoFi on many watchlists, as investors reassess what they are willing...

Annaly Capital Management (NYSE:NLY) has declared quarterly preferred stock dividends for Q1 2026. The announcement covers multiple preferred series, with payments scheduled according to each series' terms. The decision directly affects preferred shareholders who rely on regular income distributions. Annaly Capital Management is a large mortgage real estate investment trust focused on owning and financing mortgage assets. For income focused investors, preferred shares of mortgage REITs sit...

Exxon Mobil (XOM) is in focus after reporting its highest production in more than four decades, with record volumes from the Permian Basin and offshore Guyana, alongside sizable structural cost savings versus international peers. See our latest analysis for Exxon Mobil. The recent production records come after a strong run in the share price, with a 30 day share price return of 14.29% and a 90 day gain of 26.50%. The 1 year total shareholder return of 39.41% and 5 year total shareholder...

In early February 2026, Eaton Corporation entered into a senior unsecured delayed draw term loan facility of up to US$8.00 billion maturing on December 31, 2026, while also reporting fourth-quarter 2025 sales of US$7,055 million and net income of US$1,132 million, alongside full-year 2025 sales of US$27,448 million and net income of US$4,087 million. The company coupled these past results with 2026 guidance calling for mid‑single‑digit to high‑single‑digit organic growth and higher earnings...

Recurring customer complaints about see through leggings, including the Heart Scatter and earlier Get Low lines, have resurfaced concerns about lululemon athletica's product quality. The issues are emerging during an ongoing CEO transition and at a time when activist investors are pushing for changes to the board. These product and governance pressures are raising fresh questions about the brand's direction and oversight. For investors tracking NasdaqGS:LULU, the timing of these complaints...

In early February 2026, Chilwa Minerals Limited announced it had appointed Bank of New York Mellon as depositary bank for a sponsored ADR program, a key step as Chilwa advances toward a planned Nasdaq listing and seeks broader access to U.S. capital markets. This move reinforces BNY’s role at the center of cross-border capital flows by using its ADR infrastructure to connect overseas issuers with U.S. investors. We’ll now examine how BNY’s expanding ADR role for issuers like Chilwa Minerals...

Crocs (CROX) has jumped back onto investors’ radar after fourth quarter earnings and revenue exceeded analyst expectations, sparking a sharp share price move and renewed interest in the footwear maker. See our latest analysis for Crocs. Despite a 22.4% 90 day share price return and a 16.6% 30 day share price return up to the latest close of $96.88, Crocs’ 1 year total shareholder return of 9.8% decline and 3 year total shareholder return of 18.4% decline suggest that recent momentum follows a...

If you are wondering whether Fluor's current share price gives you good value, this article walks through what the numbers say about the stock and how to interpret them. Fluor recently closed at US$45.48, with returns of 3.4% over the last 30 days, 9.1% year to date and 14.4% over the past year, while the last 7 days saw a 5.5% decline. Recent news around Fluor has focused on its role as a major engineering and construction group and how investors view its project pipeline and sector...

Arcellx announced that a late-breaking abstract on its BCMA-directed CAR T therapy anitocabtagene autoleucel (anito-cel), featuring its novel D-Domain binder, was accepted and presented at the 2026 Tandem Meetings, highlighting preclinical data in relapsed or refractory multiple myeloma. The preclinical poster suggested that the compact D-Domain binder avoided tonic signaling and off-target activity seen with some other BCMA CAR constructs, potentially pointing to a differentiated safety...

If you are wondering whether Nutanix at around US$41.76 is a bargain or a value trap, you are not alone. This article is here to walk you through what the current price might be telling you. The stock has had a mixed run, with a 0.3% decline over the last week, an 8.7% decline over the past month, a 17.5% decline year to date, but returns of 50.1% over 3 years and 30.6% over 5 years that may still catch the eye of longer term investors. Recent coverage has focused on Nutanix as a key player...

In recent weeks, Invesco reported revenue growth of 8.8% year on year, surpassing analyst expectations on revenue, EBITDA, and EPS while continuing to emphasize ETFs, digital initiatives, and private markets as key business areas. At the same time, Invesco has drawn attention with a dividend yield above its industry average, a history of dividend increases, and internal commentary highlighting opportunities in discounted UK equities and sector-focused ETFs. We’ll now examine how Invesco’s...

Ball (BALL) has been in focus after reporting fourth quarter and full year 2025 results alongside fresh 2026 guidance, combining detailed earnings figures with a projection for comparable diluted EPS growth of more than 10%. See our latest analysis for Ball. The recent earnings beat and 2026 guidance have arrived after a strong run in the share price, with a 30 day share price return of 19.99% and a 90 day share price return of 41.45%. The 1 year total shareholder return of 37.08% contrasts...